Telana, a market-leading technology consultancy today announced the successful renewal of its Microsoft Azure Expert Managed Service Provider (MSP) status. The accreditation follows a rigorous, ...
Akamai (AKAM) shifts from CDN to cloud & security growth on a $1.8B contract; see 2026–27 forecasts, valuation and AI ...
Read this guest blog by Evgen Temchenko, Head of Engineering at NIX, exploring enterprise intelligent automation in the UK, ...
Innovent Biologics, Inc. (01801.HK) and Spero Therapeutics, Inc. today announced an exclusive license agreement for IBI355 (Spero R&D code: SP001), a third-generation Fc-silent anti-CD40L antibody.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results